- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07661355
Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
For all patients, the transition from hospital to home is a vulnerable period, placing them at great risk for adverse events. In a landmark 2003 report on care transitions, investigators found that 19% of patients experience adverse events soon after discharge (many preventable or ameliorable) and 66% experience adverse drug events. Care transitions also impact those around the recently discharged patient - increasing the burden on family members who provide caregiving support. Without communication and engagement in care transitions, family members experience reduced preparedness for their post-discharge caregiving role, increased caregiver burden, social isolation, and reduced mental/physical well-being.
Patient-centered care transitions can be supported through evidence-based interventions. Recent knowledge generated through PCORI's Transitional Care Evidence to Action Network and other research programs has identified remaining evidence gaps. This Phased Large Award for Comparative Effectiveness Research entitled Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers will create new knowledge related to engaging and supporting family caregivers. After optimization in the feasibility phase, briefly, the Phase 2 comparative effectiveness trial will have the following characteristics:
Setting: 20 Acute Care Hospitals across 5 states selected for rural/urban diversity and patient characteristics Sample: Dyads: Older Adults (N = 1,200) discharged to home and their Family Caregivers (N = 1,200)
Comparators:
Comparator A is an active care transition program that includes effective strategies focused on the patient.
Comparator B includes all Comparator A active strategies, plus focused family caregiver engagement and support.
Randomization:
1:1 Dyad-level RCT stratified by rural/urban home setting and presence of patient cognitive impairment
Patient-Centered Outcomes Include: Patient remaining safely at home (60-day hospital free days), post-discharge adverse events, patient-reported outcomes (e.g.: role functioning). Also, this study extends beyond prior effectiveness research by assessing family-caregiver-reported outcomes (e.g.: caregiver burden).
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Michiyah Kimber
- Номер телефона: 336-716-2236
- Электронная почта: michiyah.kimber@advocatehealth.org
Учебное резервное копирование контактов
- Имя: Erica Hale
- Номер телефона: 3367162236
- Электронная почта: erica.hale@advocatehealth.org
Места учебы
-
-
North Carolina
-
Bermuda Run, North Carolina, Соединенные Штаты, 27006
- Рекрутинг
- Davie Medical Center
-
Контакт:
- Houston
- Номер телефона: 508-688-4341
- Электронная почта: Thomas.Houston@advocatehealth.org
-
High Point, North Carolina, Соединенные Штаты, 27262
- Рекрутинг
- High Point Medical Center
-
Контакт:
- Houston
- Номер телефона: 508-688-4341
- Электронная почта: Thomas.Houston@advocatehealth.org
-
North Wilkesboro, North Carolina, Соединенные Штаты, 28659
- Рекрутинг
- Atrium Health Wake Forest Baptist Wilkes Medical Center
-
Контакт:
- Houston
- Номер телефона: 508-688-4341
- Электронная почта: Thomas.Houston@advocatehealth.org
-
Winston-Salem, North Carolina, Соединенные Штаты, 27157
- Рекрутинг
- Atrium Health Wake Forest Baptist Medical Center
-
Контакт:
- Houston
- Номер телефона: 508-688-4341
- Электронная почта: Thomas.Houston@advocatehealth.org
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Описание
Patient Inclusion Criteria:
- 65 and older
- English and Spanish speaking
- Preadmission location: community dwelling
- Distance from Hospital: Local and Distant (rural) included
- Cognitive impairment, dementia allowed
- Technology Literacy: Flexible from high to low
- EPIC readmission risk score over 12
- Discharged home
Patient Exclusion Criteria:
- Admitted from skilled nursing facility
- Discharged to skilled nursing facility
- Left Against Medical Advice (AMA)
- Planned readmission
- Died during index admission
- Caregiver unwilling to participate
Caregiver Inclusion Criteria:
- Adults 18 and older
- English and Spanish speaking
- Providing tangible support to patient
- Distance from Hospital: Local and Distant (rural) included
- Only Mild Cognitive Impairment allowed
- Able to be trained in Video Visit Technology
- Available to support post-discharge
Caregiver Exclusion Criteria:
• Has a greater than a mild cognitive impairment (< 12 on MCA)
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Активный компаратор: Patient Focused Strategies
An active care transition program that includes effective strategies focused on the patient.
|
Effective strategies focused on the patient such as patient needs assessment, multi-disciplinary discharge planning, discharge instructions, follow-up education, and follow-up assessments.
|
|
Экспериментальный: Patient and Family Focused Strategies
An active care transition program that includes effective strategies focused on the patient plus focused family caregiver engagement and support.
|
Effective strategies focused on the patient such as patient needs assessment, multi-disciplinary discharge planning, discharge instructions, follow-up education, and follow-up assessments.
Caregiver strategies such as a family caregiver needs assessment, structured education, and skill building.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Hospital-Free Days
Временное ограничение: Day 60
|
The count of days alive and outside acute care hospitals from discharge to day 60.
It will be calculated using EHR and Medicare claims data to objectively capture hospital free days elements (i.e.: mortality days, inpatient days, observation stays, and ED visits).
|
Day 60
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Number of Hospital-Free Days
Временное ограничение: Day 30, 90, and 180
|
The count of days alive and outside acute care hospitals from discharge to a specified day.
It will be calculated using EHR and Medicare claims data to objectively capture hospital free days elements (i.e.: mortality days, inpatient days, observation stays, and ED visits).
|
Day 30, 90, and 180
|
|
Number of Patient Readmissions
Временное ограничение: Day 30, 60, and 90
|
All-cause, acute care readmissions calculated as both a count and dichotomous using EHR and Medicare claims data.
|
Day 30, 60, and 90
|
|
Zarit Burden Interview Score
Временное ограничение: Day 60
|
Caregiver burden will be measured using the 12-item Zarit Burden Interview.
Scores will range from 0 to 48.
Higher scores indicate greater burden.
|
Day 60
|
|
Zarit Burden Interview Score
Временное ограничение: Day 30, 90, and 180
|
Caregiver burden will be measured using the 12-item Zarit Burden Interview.
Scores will range from 0 to 48.
Higher scores indicate greater burden.
|
Day 30, 90, and 180
|
|
PROMIS Ability to Participate in Social Roles and Activities 8-item short form (APS-SF8) Score
Временное ограничение: Day 60
|
Social role function is one's ability to perform usual social roles and activities (e.g.: leisure, family).
It will be measured by using the APS-SF8.
Each item is scored using a 5-point Likert scale (1=Never, 5=Always).
Scores are typically converted to a standardized T-score, with a mean of 50 and a standard deviation of 10.
|
Day 60
|
|
PROMIS Ability to Participate in Social Roles and Activities 8-item short form (APS-SF8) Score
Временное ограничение: Day 30, 90 and 180
|
Social role function is one's ability to perform usual social roles and activities (e.g.: leisure, family).
It will be measured by using the APS-SF8.
Each item is scored using a 5-point Likert scale (1=Never, 5=Always).
Scores are typically converted to a standardized T-score, with a mean of 50 and a standard deviation of 10.
|
Day 30, 90 and 180
|
|
Partners at Care Transitions Measure (PACT-M) - Patient Satisfaction Score
Временное ограничение: Day 7
|
Patient satisfaction will be measured using the 9-item PACT-M-1.
Scores will range from 9 to 45. Higher scores indicate better perception of the quality of discharge arrangements.
|
Day 7
|
|
Partners at Care Transitions Measure (PACT-M) - Patient Self-Efficacy Score
Временное ограничение: Day 30
|
Patient self-efficacy will be measured using the 8-item PACT-M-2.
Scores will range from 8 to 40.
Higher scores indicate a better experience with managing care at home.
|
Day 30
|
|
Patient Activation Measures Score
Временное ограничение: Day 60
|
Patient activation will be measured using the 13-item Patient Activation Measures.
Scores will range from 0 to 100.
Higher scores indicate greater knowledge, skills, and confidence for managing their health and health care.
|
Day 60
|
|
Preparedness for Caregiving Scale Score
Временное ограничение: Day 7
|
Family caregiver preparedness will be measured using the 8-item Preparedness for Caregiving Scale.
Scores will range from 0 to 32.
Higher scores indicate better preparedness for the caregiving role.
|
Day 7
|
|
Caregiver Self-Efficacy Scale Score
Временное ограничение: Day 30
|
Family caregiver self-efficacy will be measured using the 8-item Caregiver Self-Efficacy Scale.
Scores will range from 8 to 80. Higher scores indicate higher self-efficacy.
|
Day 30
|
|
Caregiver Activation Measures Score
Временное ограничение: Day 60
|
Patient activation will be measured using the 13-item Caregiver Activation Measures.
Scores will range from 0 to 100.
Higher scores indicate greater knowledge, skills, and confidence for managing their health and health care.
|
Day 60
|
|
Visit Completion Rate
Временное ограничение: Day 14 and 30
|
Number of patients that completed follow-up visit
|
Day 14 and 30
|
|
Time to First Outpatient Follow-up
Временное ограничение: Day 14 and 30
|
Number of days between discharge and first outpatient follow-up visit
|
Day 14 and 30
|
|
Rate of Access to Community Services - Patient
Временное ограничение: Day 30 and 60
|
Number of patients that had screening and intervention assessment for unmet social needs.
|
Day 30 and 60
|
|
Rate of Access to Community Services - Caregiver
Временное ограничение: Day 30 and 60
|
Number of caregivers that had screening and intervention assessment for unmet social needs
|
Day 30 and 60
|
|
Partners at Care Transitions Measures - Adverse Events Score
Временное ограничение: Day 7 and 30
|
Adverse events will be measured using the 7-item Partners at Care Transitions Measures.
Scores will range from 7 to 30.
Higher scores indicate greater care problems and more adverse events post discharge.
|
Day 7 and 30
|
|
Mortality Rate
Временное ограничение: Day 60 and 180
|
Count of days to date of patient death
|
Day 60 and 180
|
|
Montreal Cognitive Assessment 5-minute Protocol Score
Временное ограничение: Day 0, 60, and 180
|
Cognitive function (attention, orientation, language, memory, and executive function) will be measured using the Montreal Cognitive Assessment 5-min protocol.
Scores will range from 0 to 30.
Higher scores indicate better cognitive function.
|
Day 0, 60, and 180
|
Соавторы и исследователи
Следователи
- Главный следователь: Thomas Houston, MD, Wake Forest University Health Sciences
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- IRB00145199
- PLACER-2025C1-43844 (Другой номер гранта/финансирования: Patient Centered Outcomes Research Institute)
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .